Cite
HARVARD Citation
Kameda, H. et al. (2020). Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA). Modern rheumatology. 30 (2), pp. 239-248. [Online].